Compass Pathways Plc (CMPS)
7.91
-0.07
(-0.88%)
USD |
NASDAQ |
Nov 18, 10:54
Compass Pathways EPS Diluted (Quarterly) : -0.3112 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.3112 |
| June 30, 2026 | -1.883 |
| March 31, 2026 | -0.3044 |
| December 31, 2025 | -1.001 |
| September 30, 2025 | -1.436 |
| June 30, 2025 | -0.4165 |
| March 31, 2025 | -0.2011 |
| December 31, 2024 | -0.627 |
| September 30, 2024 | -0.5687 |
| June 30, 2024 | -0.5579 |
| March 31, 2024 | -0.5476 |
| December 31, 2023 | -0.5296 |
| September 30, 2023 | -0.6688 |
| June 30, 2023 | -0.6238 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.5717 |
| December 31, 2022 | -0.7309 |
| September 30, 2022 | -0.4283 |
| June 30, 2022 | -0.491 |
| March 31, 2022 | -0.5007 |
| December 31, 2021 | -0.6112 |
| September 30, 2021 | -0.3783 |
| June 30, 2021 | -0.4391 |
| March 31, 2021 | -0.3512 |
| December 31, 2020 | -0.5279 |
| September 30, 2020 | -0.4646 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.9306 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.075 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.4704 |
| Mereo BioPharma Group Plc | -0.0364 |
| HemoGenyx Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.826M |
| Total Expenses (Quarterly) | 9.826M |
| Enterprise Value | 740.63M |
| Earnings Yield | -44.24% |
| Normalized Earnings Yield | -38.24 |